Skip to main content

Table 2 Patients’ disease and treatment characteristics

From: Does a 6-point scale approach to post-treatment 18F-FDG PET-CT allow to improve response assessment in head and neck squamous cell carcinoma? A multicenter study

Characteristic

No. of patients (%) n = 119

Median age, years (range)

60 (19-84)

Sex

 Male

88 (73.9)

 Female

31 (26.1)

ECOG performance status

 

 0

80 (67.2)

 1

35 (29.4)

 2

4 (3.4)

Charlson comorbidity index (age-adjusted)

 < 4

53 (44.5)

 4-7

61 (51.3)

 ≥ 8

5 (4.2)

Smoking history (pack/years)

 0

19 (21.2)

 < 10

15 (16.6)

 10-20

11 (12.2)

 > 20

45 (50.0)

Primary tumor

 Oropharynx

68 (57.1)

 Larynx

19 (15.8)

 Hypopharynx

10 (8.5)

 Nasopharynx

22 (18.6)

HPV status (oropharynx only)

 Positive

32 (47.0)

 Negative

22 (32.4)

 Unknown

14 (20.6)

T stage at diagnosis (VIIth ed)

 1

11 (9.3)

 2

36 (30.2)

 3

31 (26.0)

 4a/4b

41 (34.5)

N stage at diagnosis (VIIth ed)

 0

26 (21.9)

 1

19 (16.0)

 2a/2b/2c

73 (61.4)

 3

1 (0.7)

AJCC stage at diagnosis (VIIth ed)

 I-II

10 (8.4)

 III

27 (22.7)

 IVA

76 (63.9)

 IVB

6 (5.0)

Primary treatment modality

 RT

14 (11.8)

 Induction CT + RT

2 (1.7)

 Induction CT + RCT

23 (19.3)

 Induction CT + BRT

2 (1.7)

 CRT

65 (54.6)

 BRT

13 (10.9)